Baquero F, Negri M C
Department of Microbiology, Hospital Ramón y Cajal, Madrid, Spain.
J Chemother. 1997 May;9 Suppl 3:29-37.
The choice of appropriate antimicrobial agents should take into consideration not only the interests of the individual patient, but also the ecological impact of different drugs and their delivery schedules. Selection of antibiotic-resistant organisms is a key aspect to remember. Bacterial populations harboring determinants of antibiotic resistance will be selected for by a range of antibiotic concentrations which are able to suppress or slow the growth of susceptible populations. These concentrations (selective concentrations) will be achieved within the human body in a series of compartments (selective compartments), where the potential selective power will be roughly proportional to the time of exposure of the bacteria to the drug (selective period). The duration of the expected exposure of bacterial populations to these concentrations of the drugs and the number of challenges they experience are probably the most important factors in predicting the potential selective activity of an antibiotic regimen. Such a risk analysis procedure may be used to propose guidelines for minimizing the development of antibiotic resistance.
选择合适的抗菌药物不仅应考虑个体患者的利益,还应考虑不同药物及其给药方案对生态的影响。记住选择抗生素耐药菌是一个关键方面。携带抗生素耐药决定因素的细菌群体将被一系列能够抑制或减缓敏感群体生长的抗生素浓度所选择。这些浓度(选择浓度)将在人体的一系列隔室(选择隔室)中达到,其中潜在的选择能力将大致与细菌接触药物的时间(选择期)成正比。细菌群体预期接触这些药物浓度的持续时间以及它们所经历的挑战次数可能是预测抗生素治疗方案潜在选择活性的最重要因素。这样的风险分析程序可用于提出将抗生素耐药性发展降至最低的指导原则。